AII
BLFS icon

AGF Investments Inc’s BioLife Solutions BLFS Stock Holding History

AGF Investments Inc’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-179
Closed -$8K – 741
2021
Q2 		$8K Buy
179
+65
+57% +$2.29K ﹤0.01% 705
2021
Q1 		$4K Buy
+114
New +$4.51K ﹤0.01% 726

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

AGF Investments Inc's BLFS Position: Q3 2021 in Review

AGF Investments Inc sold out of BioLife Solutions (BLFS) in Q3 2021, closing a stake of 179 shares — an estimated $8K sold.

AGF Investments Inc first reported a position in BLFS in Q1 2021 and held it in 2 quarters. The position peaked at $8K in Q2 2021. 165 funds tracked by Wall St. Rank hold BLFS as of Q3 2021.

  • AGF Investments Inc reported no remaining BioLife Solutions position as of Q3 2021 after selling out during the quarter.
  • AGF Investments Inc sold 179 BioLife Solutions shares in Q3 2021, an estimated $8K.
  • AGF Investments Inc first reported a position in BioLife Solutions in Q1 2021 and held it in 2 quarters.
  • AGF Investments Inc's BioLife Solutions position peaked at $8K in Q2 2021.
  • 165 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2021.

Based on AGF Investments Inc's 13F filing for Q3 2021, filed 10 Nov 2021.